presents

Julien’s Auctions Presents Exclusive Bob Dylan Auction Featuring Al Aronowitz Archive and T Bone Burnett’s Ionic Original Recording

LOS ANGELES, Dec. 17, 2024 /PRNewswire/ -- Julien's Auctions will present "Celebrating Bob Dylan: The Aronowitz Archive, T Bone Burnett,…

4 days ago

Julien’s Auctions Presents Exclusive Bob Dylan Auction Featuring Al Aronowitz Archive and T Bone Burnett’s Ionic Original Recording

LOS ANGELES, Dec. 17, 2024 /PRNewswire/ -- Julien's Auctions will present "Celebrating Bob Dylan: The Aronowitz Archive, T Bone Burnett,…

5 days ago

Julien’s Auctions Presents Exclusive Bob Dylan Auction Featuring Al Aronowitz Archive and T Bone Burnett’s Ionic Original Recording

LOS ANGELES, Dec. 17, 2024 /PRNewswire/ -- Julien's Auctions will present "Celebrating Bob Dylan: The Aronowitz Archive, T Bone Burnett,…

5 days ago

Julien’s Auctions Presents Exclusive Bob Dylan Auction Featuring Al Aronowitz Archive and T Bone Burnett’s Ionic Original Recording

LOS ANGELES, Dec. 17, 2024 /PRNewswire/ -- Julien's Auctions will present "Celebrating Bob Dylan: The Aronowitz Archive, T Bone Burnett,…

5 days ago

Celcuity Presents Overall Survival Data from Phase 1b Study Evaluating Gedatolisib in Combination with Palbociclib and Endocrine Therapy at the 2024 San Antonio Breast Cancer Symposium

December 11, 2024 07:05 ET | Source: Celcuity Inc. Median overall survival (OS) among patients with HR+, HER2- advanced breast…

2 weeks ago

Disc Medicine Presents Positive Clinical and Translational Data Across Portfolio at the 66th American Society of Hematology (ASH) Annual Meeting

December 09, 2024 12:00 ET | Source: Disc Medicine Inc  Positive updates across all programs, including updates from ongoing clinical…

2 weeks ago

CRISPR Therapeutics Presents Data atthe 2024 American Society of Hematology (ASH) Annual Meeting

December 09, 2024 12:00 ET | Source: CRISPR Therapeutics AG -Preliminary data demonstrate that CTX112™ has the potential to provide…

2 weeks ago

Agios Presents Positive Results from Phase 3 ENERGIZE-T Study of Mitapivatat ASH 2024 and Provides Regulatory Update on Mitapivat

– ENERGIZE-T Study Achieved Primary and All Key Secondary Endpoints in Adult Patients with Transfusion-Dependent Alpha- or Beta-Thalassemia – –…

2 weeks ago

C4 Therapeutics Presents Cemsidomide Phase 1 Data at the American Society for Hematology (ASH) Annual Meeting that Demonstrated Potential to Become Best-in-Class IKZF1/3 Degrader

December 08, 2024 12:30 ET | Source: C4 Therapeutics, Inc. In Multiple Myeloma, Cemsidomide in Combination with Dexamethasone at Highest…

2 weeks ago

Y-mAbs Presents SADA Platform Preclinical Data and Trial in Progress Posters at the 2024 American Society Hematology (ASH) Annual Meeting

December 07, 2024 12:00 ET | Source: Y-mAbs Therapeutics, Inc. NEW YORK, Dec. 07, 2024 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics,…

2 weeks ago